chr20-3660579-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_022139.4(GFRA4):c.584G>A(p.Arg195Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000214 in 1,399,040 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_022139.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GFRA4 | NM_022139.4 | c.584G>A | p.Arg195Gln | missense_variant | 4/6 | ENST00000290417.7 | NP_071422.1 | |
GFRA4 | NM_145762.3 | c.674G>A | p.Arg225Gln | missense_variant | 3/5 | NP_665705.1 | ||
GFRA4 | XM_005260793.2 | c.*46G>A | downstream_gene_variant | XP_005260850.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GFRA4 | ENST00000290417.7 | c.584G>A | p.Arg195Gln | missense_variant | 4/6 | 1 | NM_022139.4 | ENSP00000290417.2 | ||
GFRA4 | ENST00000319242.8 | c.674G>A | p.Arg225Gln | missense_variant | 3/5 | 1 | ENSP00000313423.3 | |||
GFRA4 | ENST00000477160.1 | n.*46G>A | downstream_gene_variant | 1 | ENSP00000435801.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.00000678 AC: 1AN: 147444Hom.: 0 AF XY: 0.0000126 AC XY: 1AN XY: 79580
GnomAD4 exome AF: 0.00000214 AC: 3AN: 1399040Hom.: 0 Cov.: 40 AF XY: 0.00000435 AC XY: 3AN XY: 690090
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 26, 2024 | The c.674G>A (p.R225Q) alteration is located in exon 3 (coding exon 3) of the GFRA4 gene. This alteration results from a G to A substitution at nucleotide position 674, causing the arginine (R) at amino acid position 225 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at